filmov
tv
Advances in the treatment of high-risk multiple myeloma
Показать описание
At the Myeloma 2015 meeting, Prof Michele Cavo (Bologna University School of Medicine, Bologna, Italy) discusses the heterogeneity and treatment recommendations for high-risk multiple myeloma. Emerging therapeutic strategies in clinical development, including lenalidomide and bortezomib-based treatment regimens, are showing promising activity for this patient group.
0:00:36
0:06:20
1:02:55
0:02:46
0:12:09
0:02:02
0:04:32
0:03:30
0:29:28
0:01:57
0:02:41
0:01:49
0:03:40
0:03:29
0:05:12
0:01:42
0:08:23
0:29:01
0:32:37
0:01:19
0:02:29
0:05:22
1:18:51
0:02:24